Stephanie Quintero Chaconhad already spent two weeks navigating a life-threatening brain hemorrhage and multiple hospital visits when she began NYU Langone’s Scientific and Technical Education Pathway Programs for Students (STEPPS) as a college junior. Her deeply personal health care experience—marked by delayed diagnosis and the need to self-advocate for life-saving brain surgery—became a turning point […]
From Data to Guidelines: How the MASALA Study Advanced Earlier Detection of Heart Disease in South Asians
Summary South Asians face some of the highest rates of heart disease worldwide yet have historically been underrepresented in U.S. research and clinical guidelines. The Mediators of Atherosclerosis in South Asians Living in America (MASALA) study—supported by over 24 million in grant funding from the NIH since 2010 and utilizing the Clinical and Translational Science […]
Keeping Our Heroes Safe: A Team Effort to Fight Cancer in the Fire Service
For years, the firefighting community has faced a grim reality: firefighters develop cancer and other chronic illnesses at significantly higher rates than the public. To tackle this crisis, the University of Miami Sylvester Comprehensive Cancer Center established the Sylvester Firefighter Cancer Initiative (FCI), a program designed to bridge the gap between scientific discoveries in a […]
NIH investments in clinical and translational research in Maine yield big dividends
Investing in Maine research delivers a clear, outsized return: every $1 invested through Northern New England Clinical and Translational Research pilot awards generated $26 in additional grant funding, helping Maine researchers secure more than $12 million to scale innovations that improve health and care delivery statewide. Beyond dollars, these investments translate into measurable results—like expanding […]
Using AI Technology to Increase Access to Eye Care in Rural Maine
Impact Stories Using AI Technology to Increase Access to Eye Care in Rural Maine January 29, 2026 Diabetic retinopathy (DR) is the leading cause of preventable blindness. The DR screening target recommended by the Centers for Medicare and Medicaid (67%) had never been reached at MaineHealth’s Western Maine Primary Care (WMPC) in Norway, Maine. How […]
Taking Care of First Responders in Wisconsin
dsdsdsdsds
Safe Pregnancies for Moms in Alabama
Study shows treating preexisting high blood pressure in pregnancy improves maternal and fetal outcomes https://www.uab.edu/news/health-medicine/study-shows-treating-preexisting-high-blood-pressure-in-pregnancy-improves-maternal-and-fetal-outcomes Visit the Journal of Clinical and Translational Science to learn how Dr. Alan Tita got involved in clinical research and how he navigated this award-winning research. More than 2 percent of pregnant women in the United States have chronic hypertension, […]
Diagnosing Rare Diseases Early in Massachusetts
Whole Genome Sequencing Doubles Diagnosis Rates for Genetic Disorders in Newborns A Comparative Analysis of Rapid Whole Genomic Sequencing and a Targeted Neonatal Gene Panel in Infants with a Suspected Genetic Disorder: The Genomic Medicine for Ill Neonates and Infants (GEMINI) Study Visit the Journal of Clinical and Translational Science to learn how Dr. Jonathan […]
Using AI to Save Lives in New York
Einstein-Montefiore CTSA-enabled Artificial Intelligence Technology Saves Lives https://pubmed.ncbi.nlm.nih.gov/30373653/ The Einstein-Montefiore Institute for Clinical and Translational Research (ICTR) has as its core mission the improvement of human health through research. In partnership with our NIH-funded CTSA together with investments from the technology sector and from the Montefiore Health System, a new artificial intelligence (AI) tool has […]
Discovering New Uses for an Asthma Drug in Maryland
RCT for Treatment of Food Allergies https://www.nejm.org/doi/full/10.1056/NEJMoa2312382 Press Release John Hopkins Institute for Clinical and Translational Research Principal Investigator: Robert A. Wood, MD This study sought to investigate if omalizumab, an injectable, FDA-approved medication for the treatment of asthma and other allergic conditions, could protect patients with multiple, severe food allergies from potentially life-threatening reactions. […]










